Evidence map›Paper›PMID 11030145›Full record

ArticleOncogene2000

Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.

I H Engels, A Stepczynska, C Stroh, K Lauber, C Berg, R Schwenzer, H Wajant, R U Jänicke, A G Porter, C Belka and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 259 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Kuntai Capsule Inhibited Endometriosis via Inducing Apoptosis in a Rat Model.Evidence-based complementary and alternative medicine : eCAM · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2011
    Article
  18. Apoptotic cell signaling in cancer progression and therapy.Integrative biology : quantitative biosciences from nano to macro · 2011
    Review
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

I H EngelsDepartment of Immunology and Cell Biology, University of Münster, Germany.
A Stepczynska
C Stroh
K Lauber
C Berg
R Schwenzer
H Wajant
R U Jänicke
A G Porter
C Belka
M Gregor
K Schulze-Osthoff
S Wesselborg
University of Münster · DEUniversity of Tübingen · DEUniversity of Stuttgart · DEInstitute of Molecular and Cell Biology · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caspase-8 plays an essential role in apoptosis triggered by death receptors. Through the cleavage of Bid, a proapoptotic Bcl-2 member, it further activates the mitochondrial cytochrome c/Apaf-1 pathway. Because caspase-8 can be processed also by anticancer drugs independently of death receptors, we investigated its exact role and order in the caspase cascade. We show that in Jurkat cells either deficient for caspase-8 or overexpressing its inhibitor c-FLIP apoptosis mediated by CD95, but not by anticancer drugs was inhibited. In the absence of active caspase-8, anticancer drugs still induced the processing of caspase-9, -3 and Bid, indicating that Bid cleavage does not require caspase-8. Overexpression of Bcl-x(L) prevented the processing of caspase-8 as well as caspase-9, -6 and Bid in response to drugs, but was less effective in CD95-induced apoptosis. Similar responses were observed by overexpression of a dominant-negative caspase-9 mutant. To further determine the order of caspase-8 activation, we employed MCF7 cells lacking caspase-3. In contrast to caspase-9 that was cleaved in these cells, anticancer drugs induced caspase-8 activation only in caspase-3 transfected MCF7 cells. Thus, our data indicate that, unlike its proximal role in receptor signaling, in the mitochondrial pathway caspase-8 rather functions as an amplifying executioner caspase.

Indexed as

Intracellular Signaling Peptides and ProteinsAdenocarcinomaAmino Acid Chloromethyl KetonesAntineoplastic AgentsApoptosisbcl-X ProteinBH3 Interacting Domain Death Agonist ProteinBreast NeoplasmsCarrier ProteinsCASP8 and FADD-Like Apoptosis Regulating ProteinCaspase 3Caspase 8Caspase 9CaspasesCysteine Proteinase InhibitorsEnzyme ActivationAmino Acid Chloromethyl KetonesAntineoplastic AgentsBCL2L1 protein, humanbcl-X Proteinbenzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneBH3 Interacting Domain Death Agonist ProteinBID protein, humanCarrier ProteinsCASP3 protein, humanCASP8 and FADD-Like Apoptosis Regulating ProteinCASP8 protein, humanCASP9 protein, humanCaspase 3Caspase 8Caspase 9CaspasesCFLAR protein, humanCysteine Proteinase InhibitorsEnzyme PrecursorsEtoposidefas ReceptorIntracellular Signaling Peptides and ProteinsMitomycinNeoplasm ProteinsPoly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-bcl-2

Identifiers

PMID11030145
OpenAlexW2083077527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.